Novel antipsychotic drugs /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Raven Press,
[1992]
|
| Subjects: |
Table of Contents:
- The mechanism of action of clozapine in relation to its clinical advantages / Herbert Y. Meltzer
- Org 5222: preliminary clinical results / J.M. Ad Sitsen and Maria C. Vrijmoed-de Vries
- Amperozide and some other atypical compounds with antipsychotic effect / Erik G. Christensson
- Clozapine: pattern of efficacy in treatment-restistant schizophrenia / Herbert Y. Meltzer
- Amperozide in the treatment of schizophrenic patients: a prelimanary report / Anders Björk, I. Bergman, and G. Gustavsson
- Comparison of the effects of different substituted benzamides on dopamine receptor function in the rat / Sven O. Ögren and Håkan Hall
- Remoxipride and raclopride: pharmacological background and clinical outcome / Tommy Lewander ... [et al.]
- Effects of PD 128483, a novel dopamine autoreceptor agonist, in preclinical antipsychotic tests / Thomas G. Heffner ... [et al.]
- Novel dopamine autoreceptor agonists B-HT 920 and EMD 49980 in the treatment of patients with schizophrenia / Klaus Wiedemann ... [et al.].
- (cont.) Efficacy and tolerability of SDZ HDC 912, a partial dopamine D₂ agonist, in the treatment of schizophrenia / Dieter Naber ... [et al.]
- The status of "Second Generation" selective D₁ dopamine receptor antagonists as putative atypical antipsychotics agents / John L. Waddington and Siobhan A. Daly
- Towards the understanding of the neuroanatomical substrate of schizophrenia: the contribution of savoxepine / Serge F. Bischoff
- The dopamine D₃ receptor as a target for antipsychotics / Jean-Charles Schwartz ... [et al.]
- Receptor selectivities of atypical neuroleptics / Philip Seeman
- Glutamatergic mechanisms in neuropsychiatry / John W. Olney
- Enhancement of NMDA-mediated transmission in schizophrenia: effects of milacemide / Carol A. Tamminga ... [et al.]
- Glycine in the treatment of schizophrenia: theory and preliminary results / Steven G. Potkin
- Sigma "antagonists": potential antipsychotics? / Duncan P. Taylor and R. Francis Schlemmer, Jr.
- Clinical efficacy of sigma antagonists in schizophrenia / Richard L. Borison, Ananda P. Pathiraja, and Bruce I. Diamond.
- (cont.) Antipsychotic potential of 5-HT₃ antagonists: preclinical data / Michael G. Palfreyman ... [et al.]
- The effects of a novel 5-HT₃ antagonist, ondansetron, in schizophrenia: results from uncontrolled trials / Joseph DeVeaugh-Geiss ... [et al.]
- Clinical overview of risperidone / Richard L. Borison ... [et al.]
- What makes a neuroleptic atypical? / Daniel E. Casey.